GLP-1 medication prices vary widely depending on whether you use insurance, a manufacturer cash program, or a compounded option. Knowing the real numbers helps you plan.
Quick answer: Without insurance, branded GLP-1 weight-loss drugs are expensive. Wegovy lists around $1,349 per month and Zepbound around $1,060 per month before discounts. Manufacturer self-pay programs cut this sharply: Wegovy has been offered near $499 per month through NovoCare, and Zepbound single-dose vials are available at reduced cash prices through LillyDirect. Compounded semaglutide and tirzepatide from licensed pharmacies are typically lower-cost alternatives. With commercial insurance and a savings card, some patients pay far less. Oral GLP-1 options were still in late development as of 2026.
How much do GLP-1 injections cost per month?
| Option | Approximate monthly cost | Notes |
|---|---|---|
| Wegovy (list price) | ~$1,349 | Before insurance or discounts |
| Zepbound (list price) | ~$1,060 | Before insurance or discounts |
| Wegovy (NovoCare self-pay) | ~$499 | Cash-pay program |
| Zepbound (LillyDirect vials) | Reduced, varies by dose | Single-dose vials, cash-pay |
| Compounded semaglutide/tirzepatide | Typically lower | From licensed pharmacies |
| With insurance + savings card | Often much lower | Depends on plan and eligibility |
The gap between list price and what people actually pay is large. Few patients pay full list price once cash programs, savings cards, or compounded options are factored in.
Why is GLP-1 weight loss so expensive?
Branded GLP-1 drugs carry high list prices set by manufacturers, and many insurance plans either do not cover weight-loss medication or require prior authorization and step therapy. When a plan does not cover the drug, patients face the full list price unless they use a manufacturer cash program. This pricing pressure is part of why manufacturer self-pay options and compounded alternatives became popular. The underlying drugs are protected by patents, which keeps branded competition limited until that changes.
Brand-name vs potential biosimilar and compounded options
There are no approved GLP-1 biosimilars for these specific weight-loss drugs yet, since the originals are still on patent. What exists instead are two paths to lower cost: manufacturer cash programs for branded products, and compounded semaglutide or tirzepatide prepared by licensed pharmacies. Compounded medications are a distinct category from branded drugs and are not the same product; they are made by pharmacies under different rules. When comparing options, weigh price, the credentials of the prescriber and pharmacy, dosing support, and availability rather than price alone.
See transparent compounded pricing
Review compounded medication pricing and what provider-reviewed care includes, with no surprises at checkout.
Try the Cost Calculator →Oral GLP-1 vs injectable cost
Injectable semaglutide and tirzepatide dominate the market today. Oral GLP-1 candidates, including small-molecule options like orforglipron, were in late-stage development as of 2026 and not yet broadly available for weight loss. Oral small molecules may eventually be cheaper to manufacture than peptide injectables, which could affect pricing over time, but that depends on approval and how each maker prices the product. For now, injectables remain the main route, and cost comparisons should focus on the injectable options actually available to you.
How GLP-1 cost compares to other treatments
Compared with older weight-management medications, GLP-1 drugs are more expensive but also produce larger average weight loss in the drug classes studied. For people with type 2 diabetes, some GLP-1 drugs are more likely to be covered, which can lower out-of-pocket cost relative to weight-loss-only use. The right comparison depends on your indication, your insurance, and whether a cash program or compounded option fits your budget.
How to lower your GLP-1 cost
Check whether your insurance covers the drug for your specific indication, and ask about prior authorization. Use manufacturer savings cards if you have commercial insurance, or manufacturer self-pay programs if you do not. Compare compounded semaglutide and tirzepatide from licensed pharmacies as a lower-cost route. FormBlends connects patients with licensed US pharmacies and our provider comparison tool helps you compare real options side by side. You can also review semaglutide options directly.
Frequently asked questions
How much does Wegovy cost per month? List price is about $1,349, but NovoCare self-pay has been offered near $499 per month.
How much does Zepbound cost per month? List price is about $1,060, with reduced cash prices for single-dose vials through LillyDirect.
Is compounded GLP-1 cheaper? Compounded semaglutide and tirzepatide from licensed pharmacies are typically lower-cost than branded products.
Are there GLP-1 biosimilars yet? No approved weight-loss GLP-1 biosimilars exist yet, since the originals remain on patent.
Will oral GLP-1 be cheaper? Possibly over time, but oral candidates were still in late development as of 2026.
Does insurance cover GLP-1 for weight loss? Coverage varies widely; many plans require prior authorization or do not cover weight-loss use.
What is the cheapest GLP-1 option? It depends on your insurance; compare cash programs, savings cards, and compounded options.
Sources
- Wegovy cost and NovoCare: https://www.wegovy.com/
- Zepbound and LillyDirect: https://www.lilly.com/news
See your options in about 2 minutes
Take the free quiz and see what fits you. Quick, private, and no commitment to continue.
See my options →